Results 1 to 10 of about 4,166,301 (304)

Data mining techniques for detecting signals of adverse drug reaction of cardiac therapy drugs based on Jinan adverse event reporting system database: a retrospective study

open access: yesBMJ Open, 2023
Objective Cardiac therapy drugs are widely used in the treatment of heart disease. However, the concern regarding adverse events (AEs) of cardiac therapy drugs have been rising. This study aimed to analyse cardiac therapy drug-related AEs using the Jinan
Jing Yang   +6 more
doaj   +1 more source

SARS-CoV-2 vaccine excipients polyethylene glycol and trometamol do not induce mast cell degranulation, in an in vitro model for non-IgE-mediated hypersensitivity

open access: yesFrontiers in Allergy, 2022
The development of vaccines against SARS-CoV2 brought about several challenges, including the management of hypersensitivity reactions to these formulations.
Paola Leonor Quan   +17 more
doaj   +1 more source

Differences in Linear Epitopes of Ara h 9 Recognition in Peanut Allergic and Tolerant, Peach Allergic Patients

open access: yesFrontiers in Allergy, 2022
BackgroundPeanut-allergic patients from the Mediterranean region are predominantly sensitized to the lipid transfer protein (LTP) Ara h 9, and the peach LTP Pru p 3 seems to be the primary sensitizer. However, LTP sensitization in peanut allergy is not a
L. Sánchez-Ruano   +11 more
doaj   +1 more source

Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance

open access: yesFrontiers in Allergy, 2022
BackgroundThe newly developed mRNA-based COVID-19 vaccines can provoke anaphylaxis, possibly induced by polyethylene glycol (PEG) contained in the vaccine.
Florian Stehlin   +11 more
doaj   +1 more source

MRGPRX2 and Adverse Drug Reactions

open access: yesFrontiers in Immunology, 2021
Many adverse reactions to therapeutic drugs appear to be allergic in nature, and are thought to be triggered by patient-specific Immunoglobulin E (IgE) antibodies that recognize the drug molecules and form complexes with them that activate mast cells ...
Benjamin D. McNeil
doaj   +1 more source

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline

open access: yesmAbs, 2020
Monoclonal antibody (mAb) therapy has been previously exploited for viral infections, such as respiratory syncytial virus pneumonia and Ebolavirus disease.
Marco Tuccori   +7 more
doaj   +1 more source

Activity of Moxifloxacin Against Biofilms Formed by Clinical Isolates of Staphylococcus aureus Differing by Their Resistant or Persister Character to Fluoroquinolones

open access: yesFrontiers in Microbiology, 2021
Staphylococcus aureus biofilms are poorly responsive to antibiotics. Underlying reasons include a matrix effect preventing drug access to embedded bacteria, or the presence of dormant bacteria with reduced growth rate.
Tiep K. Nguyen   +7 more
doaj   +1 more source

A study on the knowledge, attitude, and practice on adverse drug reactions and pharmacovigilance among nursing staff

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2023
Background: Lack of knowledge of pharmacovigilance and underreporting of adverse drug reaction (ADR) are worldwide problems of big concern. Gross underreporting of ADR in India led to increased hospital admissions, increase in length of hospital stay ...
Akanksha Tiwari   +3 more
doaj   +1 more source

Safety Profile of Biological Drugs in Clinical Practice: A Retrospective Pharmacovigilance Study

open access: yesIraqi Journal of Pharmaceutical Sciences, 2022
Biological drugs have an active substance that is made by a living organism or derived from a living organism. They are one of the important therapy options used in a wide range of diseases especially life-threatening diseases.
Elaaf Fadhil Hassan   +2 more
doaj   +1 more source

Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2020
Background/Aims Teicoplanin can be used as an alternative to vancomycin when treating beta-lactam-resistant gram-positive bacterial infections. Both vancomycin and teicoplanin are associated with relatively high rates of adverse drug reactions (ADRs ...
Byung-Keun Kim   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy